-
1دورية أكاديمية
المؤلفون: Vikram Jairam, MD, Pamela R. Soulos, MPH, Madhav K.C., PhD, MPH, Cary P. Gross, MD, Ben J. Slotman, MD, PhD, Anne C. Chiang, MD, PhD, Henry S. Park, MD, MPH
المصدر: Advances in Radiation Oncology, Vol 9, Iss 4, Pp 101413- (2024)
مصطلحات موضوعية: Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المصدر: International Journal of Infectious Diseases, Vol 109, Iss , Pp 189-191 (2021)
مصطلحات موضوعية: Infectious and parasitic diseases, RC109-216
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Michelle C. Salazar, MD, Maureen E. Canavan, PhD, Samantha L. Walters, BS, Sitaram Chilakamarry, MD, Theresa Ermer, MD, Justin D. Blasberg, MD, James B. Yu, MD, MHS, Cary P. Gross, MD, Daniel J. Boffa, MD
المصدر: JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100143- (2021)
مصطلحات موضوعية: Non–small cell lung cancer, Stage I, Lobectomy, Wedge, Mortality, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المصدر: Cancer Control, Vol 27 (2020)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1073-2748
-
5دورية أكاديمية
المؤلفون: Yu JB; James B. Yu, MD, MHS, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Radiation Oncology, St Francis Hospital, Hartford, CT; David M. DeStephano, MPH and David P. Horowitz, MD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY; Cary P. Gross, MD, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Internal Medicine and Primary Care, Yale School of Medicine, New Haven, CT; and Simon K. Cheng, MD, PhD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY., DeStephano DM; James B. Yu, MD, MHS, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Radiation Oncology, St Francis Hospital, Hartford, CT; David M. DeStephano, MPH and David P. Horowitz, MD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY; Cary P. Gross, MD, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Internal Medicine and Primary Care, Yale School of Medicine, New Haven, CT; and Simon K. Cheng, MD, PhD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY., Horowitz DP; James B. Yu, MD, MHS, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Radiation Oncology, St Francis Hospital, Hartford, CT; David M. DeStephano, MPH and David P. Horowitz, MD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY; Cary P. Gross, MD, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Internal Medicine and Primary Care, Yale School of Medicine, New Haven, CT; and Simon K. Cheng, MD, PhD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY., Gross CP; James B. Yu, MD, MHS, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Radiation Oncology, St Francis Hospital, Hartford, CT; David M. DeStephano, MPH and David P. Horowitz, MD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY; Cary P. Gross, MD, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Internal Medicine and Primary Care, Yale School of Medicine, New Haven, CT; and Simon K. Cheng, MD, PhD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY., Cheng SK; James B. Yu, MD, MHS, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Radiation Oncology, St Francis Hospital, Hartford, CT; David M. DeStephano, MPH and David P. Horowitz, MD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY; Cary P. Gross, MD, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, New Haven, CT, Department of Internal Medicine and Primary Care, Yale School of Medicine, New Haven, CT; and Simon K. Cheng, MD, PhD, Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY.
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 30, pp. JCO2401228. Date of Electronic Publication: 2024 Jul 30.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
-
6Editorial & Opinion
المؤلفون: Huntington SF; Scott F. Huntington, MD, Yale University, New Haven, CT; Gottfried von Keudell, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY; Amy J. Davidoff, PhD, Yale University School of Public Health, New Haven, CT; Cary P. Gross, MD, Yale University School of Medicine, New Haven, CT; and Sapna A. Prasad, PhD, Yale-New Haven Hospital, New Haven, CT., von Keudell G; Scott F. Huntington, MD, Yale University, New Haven, CT; Gottfried von Keudell, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY; Amy J. Davidoff, PhD, Yale University School of Public Health, New Haven, CT; Cary P. Gross, MD, Yale University School of Medicine, New Haven, CT; and Sapna A. Prasad, PhD, Yale-New Haven Hospital, New Haven, CT., Davidoff AJ; Scott F. Huntington, MD, Yale University, New Haven, CT; Gottfried von Keudell, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY; Amy J. Davidoff, PhD, Yale University School of Public Health, New Haven, CT; Cary P. Gross, MD, Yale University School of Medicine, New Haven, CT; and Sapna A. Prasad, PhD, Yale-New Haven Hospital, New Haven, CT., Gross CP; Scott F. Huntington, MD, Yale University, New Haven, CT; Gottfried von Keudell, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY; Amy J. Davidoff, PhD, Yale University School of Public Health, New Haven, CT; Cary P. Gross, MD, Yale University School of Medicine, New Haven, CT; and Sapna A. Prasad, PhD, Yale-New Haven Hospital, New Haven, CT., Prasad SA; Scott F. Huntington, MD, Yale University, New Haven, CT; Gottfried von Keudell, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY; Amy J. Davidoff, PhD, Yale University School of Public Health, New Haven, CT; Cary P. Gross, MD, Yale University School of Medicine, New Haven, CT; and Sapna A. Prasad, PhD, Yale-New Haven Hospital, New Haven, CT.
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Apr 01; Vol. 37 (10), pp. 853-854. Date of Electronic Publication: 2019 Feb 11.
نوع المنشور: Letter; Comment
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Hodgkin Disease*, Brentuximab Vedotin ; Cost-Benefit Analysis ; Humans ; Positron-Emission Tomography
Full Text via ClinicalKey 
Full Text Finder